NCT05998642 2026-02-12
Ibrutinib Combination Therapy in Transplant Ineligible Individuals With Newly Diagnosed Primary CNS Lymphoma
Canadian Cancer Trials Group
Phase 2 Recruiting
Canadian Cancer Trials Group
Bioaraba Health Research Institute
SWOG Cancer Research Network
AIDS Malignancy Consortium